CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY
Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication
Early and one-year outcomes
Andrew J. Feiring, MD, FACC, FCSAI*,
Amy A. Wesolowski, RN and
Susan Lade, RN
Columbia-St. Mary's Medical Center, Milwaukee, Wisconsin
Manuscript received May 25, 2004;
revised manuscript received August 26, 2004,
accepted September 14, 2004.
* Reprint requests and correspondence: Dr. Andrew J. Feiring, Director Cardiac and Vascular Intervention, Columbia-St. Mary's Medical Center, Suite 208, 2015 East Newport Avenue, Milwaukee, Wisconsin 53211 (Email: afeiring{at}execpc.com).
OBJECTIVES: The objective of this study was an investigation of the safety and efficacy of primary below-knee stent-supported angioplasty (BKSSA) for restoring straight inline arterial flow in patients with critical limb ischemia (CLI) or lifestyle-limiting claudication (LLC).
BACKGROUND: Surgical tibial bypass for CLI and severe LLC is associated with significant morbidity, mortality, and graft failure, whereas percutaneous angioplasty is suboptimal.
METHODS: Below-knee stent-supported angioplasty was attempted in 82 patients (92 limbs) with either CLI (68%) or severe LLC (32%). Patients received daily aspirin, thienopyridine, and glycoprotein IIb/IIIa agents during the procedure. One-month major adverse events (MAEs) were defined as death, myocardial infarction, major unplanned amputation, need for surgical revascularization, or major bleeding. Clinical success was defined as improved resting ankle brachial index by 0.10, relief of resting pain, healing of ulceration or amputation, and improvement of claudication.
RESULTS: Mean age of patients was 74 ± 17 years. In 86 limbs, straight inline flow was restored to at least one tibial vessel. Technical success was 94% for de novo lesions and there were no MAEs. Ankle brachial indexes increased for all groups (CLI = 0.32 ± 0.13 to 0.9 ± 0.14 and LLC = 0.65 ± 0.09 to 0.95 ± 0.12; p 0.0001, pre vs. post). Relief of rest pain and healing of ulcerations and amputations were seen in 96% (47 of 49) of patients with CLI who underwent successful intervention.
CONCLUSIONS: Below-knee stent-supported angioplasty for CLI and LLC improves ankle brachial indexes comparable to tibial bypass, heals amputations and ulcerations, relieves rest pain, and improves ambulation. Because BKSSA is associated with minimal MAE, it may hold promise as an alternative therapy for patients with CLI and LLC.
|
Abbreviations and Acronyms
| | ABI = ankle brachial index | | BKSSA = below-knee stent-supported angioplasty | | CLI = critical limb ischemia | | DES = drug-eluting stent | | LLC = lifestyle-limiting claudication | | MAE = major adverse events | | MI = myocardial infarction | | PTA = percutaneous transluminal angioplasty |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. A Arain and C. J White
Endovascular therapy for critical limb ischemia
Vascular Medicine,
August 1, 2008;
13(3):
267 - 279.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Feiring
Footnotes on Critical Limb Ischemia
J. Am. Coll. Cardiol.,
May 20, 2008;
51(20):
1975 - 1976.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Rogers and J. R. Laird
Overview of New Technologies for Lower Extremity Revascularization
Circulation,
October 30, 2007;
116(18):
2072 - 2085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tepe, C. Hopfenzitz, K. Dietz, J. Wiskirchen, S. Heller, K. Ouriel, G. Ziemer, C. D. Claussen, and S. H. Duda
Peripheral Arteries: Treatment with Antibodies of Platelet Receptors and Reteplase for Thrombolysis--APART Trial
Radiology,
June 1, 2006;
239(3):
892 - 900.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Muhs, P. J. Gagne, T. Maldonado, and P. Sheehan
Minimally Invasive Revascularization Strategies for Chronic Lower Limb Ischemia
International Journal of Lower Extremity Wounds,
March 1, 2006;
5(1):
35 - 39.
[Abstract]
[PDF]
|
 |
|
|